Written by Marco Crisci, Senior Analyst The Association of the British Pharmaceutical Industry (ABPI) recently published a report outlining the need for new payment models,
Written by Johann Sanseáu, Senior Analyst Saudi Arabia has been progressively integrating pharmacoeconomic evaluation methods into the decision-making processes concerning the pricing and reimbursement of
Written by Iro Malekou, Senior Analyst & Srishti Gupta, Senior Consultant Emails: [email protected], [email protected] Over a year ago, the European Commission (EC) set out to
Written by: Angeliki Meletsi; Analyst Contact: [email protected] The European Commission proposals on the EU pharmaceutical legislation revision, announced in April 2023, have not included any
Written by: Srishti Gupta, PhD; Senior Consultant Contact: [email protected] In March 2023, the Food and Drug Administration (FDA) published, a first of its kind, draft
